-
Mashup Score: 0
Researchers found that metformin use was associated with improvements in OS and RFS in overweight and obese patients with NSCLC.
Source: www.pulmonologyadvisor.comCategories: General Medicine News, PulmonologyTweet
Researchers found that metformin use was associated with improvements in OS and RFS in overweight and obese patients with NSCLC.
#Metformin use was associated with longer overall survival in a cohort of patients with #NSCLC and the subgroup of patients with a #BMI of 25 or higher. Read More: https://t.co/rtlbDVB6W3